Psychiatry and Neurology, Neurology · Alexandria, VA
NPI
1740504992
Since 2010
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1500 N Beauregard St, Suite 300
Alexandria, VA, 22311
Phone (703) 845-1500
Groups this clinician bills Medicare through
Medicare paid, 2024
$122K
1,842 services
Medicare patients, 2024
589
Average age 77
Drug cost, 2024
$1.2M
3,816 prescriptions
Company payments, 2025
$733
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sean L Rogers was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 599 times for 356 patients. In total Sean L Rogers billed 1,842 services in 18 codes, and Medicare paid $122K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-11-27.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 599 | 356 | $13.77 | $8,248 |
| 99214 Office E&M - Established | Office | 535 | 379 | $79.79 | $43K |
| 99215 Office E&M - Established | Office | 355 | 270 | $104.50 | $37K |
| 99204 Office E&M - New | Office | 85 | 85 | $113.18 | $9,620 |
| 99205 Office E&M - New | Office | 55 | 55 | $142.51 | $7,838 |
| 64616 Musculoskeletal | Office | 50 | 15 | $119.05 | $5,953 |
| 95983 Electrical Nerve Conductivity | Office | 32 | 11 | $39.58 | $1,266 |
| 99213 Office E&M - Established | Office | 15 | 11 | $56.55 | $848 |
By year: 2022 $239K for 13,730 services; 2023 $143K for 1,310 services; 2024 $122K for 1,842 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sean L Rogers prescribed most often to Medicare patients was Donepezil Hcl, with 681 prescriptions and refills. In total Sean L Rogers wrote 3,816 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Donepezil Hcl Generic | 681 | 1,573 | 202 | $8,397 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 577 | 1,343 | 156 | $14K |
| Rytary Carbidopa/Levodopa | 285 | 514 | 52 | $349K |
| Rasagiline Mesylate Generic | 204 | 502 | 55 | $35K |
| Memantine Hcl Generic | 186 | 390 | 52 | $4,203 |
| Primidone Generic | 123 | 345 | 36 | $3,032 |
| Gabapentin Generic | 111 | 265 | 36 | $2,199 |
| Pramipexole Er Pramipexole Di-Hcl | 88 | 193 | 19 | $33K |
| Escitalopram Oxalate Generic | 84 | 188 | 32 | $979 |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 79 | 201 | 24 | $2,895 |
| Neupro Rotigotine | 76 | 161 | 21 | $133K |
| Topiramate Generic | 76 | 150 | 22 | $470 |
| Clonazepam Generic | 75 | 99 | 15 | $637 |
| Propranolol Hcl Generic | 73 | 131 | 18 | $1,527 |
| Mirtazapine Generic | 72 | 162 | 24 | $1,589 |
Brand drugs: 600 claims; generic drugs: 3,216 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sean L Rogers $733 ($733 in general payments such as food, travel and fees) from 9 companies. The largest payer was Abbvie Inc. with $256.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 11 | $256 |
| Supernus Pharmaceuticals, Inc. SUPN | 14 | $157 |
| Merz Pharmaceuticals, LLC | 1 | $148 |
| MDD US Operations, LLC | 9 | $39.05 |
| InSightec,Inc | 1 | $37.05 |
| Neurocrine BioSciences, Inc. NBIX | 1 | $26.21 |
| Ge Healthcare GEHC | 1 | $25.59 |
| Amneal Pharmaceuticals LLC AMRX | 1 | $22.5 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 1 | $20.46 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.